Clinical Trials on Intrathoracic Malignancies
Total 1437 results
-
Han weidongUnknownMalignancies MultipleChina
-
Massachusetts General HospitalClinical GenomicsWithdrawnGastrointestinal MalignanciesUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedLymphoid MalignanciesChina
-
Novartis PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPaediatric MalignanciesFrance
-
Hillel Yaffe Medical CenterUnknownGynecological MalignanciesIsrael
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
University of Southern CaliforniaTerminated
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced MalignanciesSpain
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
University Hospital, Clermont-FerrandAmgenUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownAdvanced MalignanciesNetherlands
-
Novartis PharmaceuticalsCompletedAdvanced MalignanciesUnited States
-
Metronome TherapeuticsUnknownNonhematologic MalignanciesUnited States
-
Rabin Medical CenterUnknownUrological MalignanciesIsrael
-
M.D. Anderson Cancer CenterRegeneron PharmaceuticalsNot yet recruitingSMARCB1-Deficient MalignanciesUnited States
-
TransThera Sciences (Nanjing), Inc.RecruitingB-Cell MalignanciesChina
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesRomania, Moldova, Republic of
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Incyte CorporationCompleted
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.Unknown
-
Samyang Biopharmaceuticals CorporationCompleted
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Gastrointestinal MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Geron CorporationCompletedSolid Tumor MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Gilead SciencesRecruiting
-
Beijing Mabworks Biotech Co., Ltd.Recruiting
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
University Medical Center GroningenTerminatedMetastatic MalignanciesNetherlands
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced MalignanciesJapan
-
R-PharmCompletedSolid MalignanciesUnited States